UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Verna Porter, MD

Print
Email

Verna Porter, MD

UCLA Physician Verna Porter, MD specializes in Neurology.
Specialty
Neurology
Gender
Female
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
A55356
Contact
(310) 319-5098
Fax Number
(310) 319-4552
Voted Super Doctor
PRACTICE LOCATION

UCLA Santa Monica Neurological Associates
1801 Wilshire Blvd
Santa Monica, CA 90403

MEDICAL BOARD CERTIFICATION
Neurology, American Board of Psychiatry and Neurology, 2000, 2009
EDUCATION
Fellowship
Neurology, UCLA School of Medicine, 1998 - 2000
Residency
Neurology, UCLA School of Medicine, 1995 - 1998
Internship
Internal Medicine, UCLA School of Medicine, 1994 - 1995
Medical Degree
MD, UCLA School of Medicine, 1994
CLINICAL INTEREST
Alzheimer's Disease, Ataxia, Cognitive, Concussion, Electroencephalogram (EEG), Facial Pain, General Neurology, Geriatric Behavior, Guillain Barre Syndrome, Head Trauma, Headache, Hydrocephalus, Memory Disorders, Movement Disorders, Multiple Sclerosis, Neuro Behavior, Neuro Otology, Neuropathy, Normal Brain Function, Parkinson's Disease, Peripheral Nerve, Sleep Disorders, Spine, Stroke
AFFILIATION
Department Affiliation
Director, Santa Monica Neurological Associates
Physician, Neurology, General Neurology Program
IN THE NEWS

UCLA Headlines (UCLA's Office of Media Relations)
Tuesday, Dec. 13, 2005:
In the News: In relation to: Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood of male patients with mild Alzheimer’s disease and healthy elderly men. Archives of Neurology. 2006 Feb; 63(2):177-85. Epub 2005 Dec 12.

ALZHEIMER'S: Research into testosterone therapy for men with Alzheimer's disease led by Po Lu, assistant clinical professor of neurology at the UCLA Alzheimer Disease Center, received coverage today from BBC News,
Asian News International (India), Ivanhoe Newswire and DeHavilland Information Services (U.K.); and was featured Monday by Health Day News, United Press International, WebMD, CNN Radio and NBC News Channel.  Web coverage of the news release and wire reports included WebIndia123.com, MonstersAndCritics.com, ScienceDaily.com, NewKerala.com (India), HealthCentral.com, AJC.com, Statesman.com and Innovations-Report.com (Germany).

MORE INFORMATION
Research Interest
Dementia and Neurodegenerative Conditions
Additional Information
UCLA Santa Monica Neurological Associates is a state of the art consultative suite that also offers a full range of consultative services for adult patients for all aspects of neurological care. The inpatient site at Santa Monica UCLA Medical Center and Orthopaedic Hospital complements this practice, which is currently a 337-bed acute-care medical center. This facility is scheduled to open a new Orthopedic Hospital and expanded facilities in the near future. This medical center has been serving the healthcare needs of West Los Angeles and Santa Monica since 1926. This center is highly regarded for its primary and specialty care. The medical center features many outstanding clinical programs, including its inpatient neurological care, women's and children's services, emergency services, family medicine, geriatric medicine, and orthopedic programs among others. Our faculty look forward to providing the traditional outstanding quality of the UCLA Neurology Clinic in this convenient community based center.
Awards & Recognition
  • Selected to be listed in the 2010 Southern California Super Doctors, Los Angeles Magazine (features top five percent of doctors in Los Angeles and Orange counties) January, 2010 Edition
  • Selected for inclusion in the 2010 Los Angeles Magazine, Top Doctors January, 2010 Edition
  • Selected for inclusion in Marquis Who’s Who in America 2009 & 2010 Editions
  • Selected for inclusion in Guide to America’s Top Physicians by the Consumers' Research Council of America (Washington, D.C. based research organization that provides consumers' information guides for professional services throughout America). 2004-2005, 2005-2006, 2006-2007, 2007-2008, 2009-2010 editions
Publications

1. Effros RB, Boucher N, Porter VR, Zhu X, Spaulding, C, Walford RL, Kronenberg M, Cohen D, Schachter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 1994 Nov-Dec; 29(6): 601-9.
2. MacKenzie-Graham AJ, Pribyl TM, Kim S, Porter VR, Campagnoni AT, Voskuhl RR. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol. 1997 Nov 1; 159(9): 4602-10.
3. Porter VR, Greendale G, Schocken M, Zhu X, Effros RB. Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol. 2001 Feb; 36(2): 311-26.
4. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging. 2003 Jan-Feb;24(1):77-84.
5. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O'Connor SM, Rosenberg-Thompson S, Cummings JL. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003 Spring; 15(2): 180-6.
6. Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Felix J, Amezcua H, Cummings JL. Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy: An FDG-PET Study. Arch Neurol. 2005 Vol 62, 721-728.
7. Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood of male patients with mild Alzheimer’s disease and healthy elderly men. Archives of Neurology. 2006 Feb; 63(2):177-85. Epub 2005 Dec 12.
8. The IMS II Trial Investigators, Porter V. The International Management of Stroke (IMS) II Study. Stroke. 2007. 38:2127-35. (Porter, V as a clinical investigator)
9. Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis. 2008 Jan-Feb;17(1):5-8.
10. CLEAR Stroke Trial Investigators, Porter VR. The Combined Approach to Lysis Using Eptifibatide and rt-PA in Acute Ischemic Stroke: The CLEAR Stroke Trial. Stroke. 2008 39:3268-76. (Porter VR as a clinical investigator).
11. Avagyan H., Goldenson B., Masoumi A., Porter V., Wiedau-Pazos M., Sayre J., Ong R, Tse E, Koo P, Bae S, Mahanian M, Micic M, Liu P, Rosenthal M., Fiala M. Immune blood biomarkers of Alzheimer disease patients. Journal of Neuroimmunology, 210 (2009), 67-72.

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Verna Porter,  click here to update your profile.